Bursting with nutrients and boasting an impressive growth rate, the future of hemp seed is bright– but what’s the best way for manufacturers to cash in on a product that is connected – mistakenly but understandably – with an illegal drug?
Omega-3 fatty acids inhibit the growth and spread of prostate cancer cells, say scientists – challenging a 2013 study which claimed omega-3s increase the risk of prostate cancer by 71%.
Journal of American Medical Association (JAMA)-published research has found vegetarian Seventh-day Adventist men and women have a lower risk of developing colorectal cancer than meat eating folks from the same religion.
Vitamin D should not be recommended to prevent chronic disease because such benefits have not been confirmed and adverse effects of over-consumption can’t be ruled out, according to a review.
The Federal Trade Commission has received confirmation of its basic positions in its struggle with POM Wonderful over the substantiation on the claims the company has made for its juice and supplement products. But the appeals court ruling offers a shred of consolation for industry too, one observer said.
Benefit-risk ratios must be established for each antioxidant separately, considering risk groups and dosage, according to researchers reviewing polarised perceptions of vitamin E and beta-carotene.
Green tea and apple compound epigallocatechin-3-gallate (EGCG) may trigger a process which sees oral cancer cells killed while healthy cells are left untouched, according to US researchers.
BioHarvest, an Israeli company harvesting dietary supplement ingredients from plants grown via a unique hydroponic method, has launched a “biofood” ingredient called VINIA Red Grape Powder, said to offer the benefits of drinking red wine without the sugar, calories or alcohol.
Vitamin D may help to reduce the risk of colorectal cancer by priming the immune system to respond against tumour cells, according to new data.
A citrus extract called limonin glucoside may decrease select markers of inflammation by as much as 40%, according to results of a double-blind placebo-controlled study in overweight/obese people.
Eat well, stress less, move more and love more: These four simple principles of lifestyle changes have been shown to have significant benefits in managing chronic disease risk, influencing aging, and reducing health care costs. And that’s why lifestyle medicine is the right idea at the right time, says Dean Ornish, MD, founder & president of the Preventive Medicine Research Institute.
Zivo Bioscience Inc. has announced a large-scale test of its WellMetris testing platform that will validate a technology that the founders say will be a game changer for dietary supplement companies and, eventually, the traditional healthcare sphere as well.
We are witnessing a revolution in healthcare comparable in impact to that which occurred at the turn of the last century with the discovery of the origin of infectious disease.
The majority of Americans are not meeting the requirements for a number of essential nutrients, but the focus of the Dietary Guidelines Advisory Committee (DGAC) on a healthy diet is causing a significant problem, says Dr Balz Frei from the Linus Pauling Institute.
Supplement usage continues to hold steady in the United States, according to the most recent survey from the Council for Responsible Nutrition. According to the survey, 68% of all US adults reported taking dietary supplements.
Ingredient supplier Maypro has extended its branded ingredient offerings via a strategic sales partnership with Wilke Industries. It’s part of the company’s push to remain relevant in the rapidly evolving ingredient supplier landscape, said Maypro executive Dan Lifton.
ChromaDex has bolstered the IP protection around pTeroPure, one of its branded ingredients, with the announcement of two patents relating to pterostilbene, which are the second and third patents granted to the company on the ingredient.
A peer-reviewed journal has pulled a panning review of omega-3 benefits as concerns about its author's conflicts of interest and credentials were flagged.
ChromaDex Corp. has announced an additional $5 million in funding from Hercules Technology Growth Capital. The cash infusion will fund operations for a number of months as the company moves toward profitability, said CEO Frank Jaksch.